Calls for more pregnant and breastfeeding women to be included in medical research

Publicly released:
Australia; International
Photo by Dave Clubb on Unsplash
Photo by Dave Clubb on Unsplash

We should reconsider blanket bans on pregnant and breastfeeding women from clinical trials, according to international researchers who say the current exclusions can lead to delays in understanding what treatments are safe and effective during pregnancy and breastfeeding. Many clinical trials exclude women who are pregnant, breastfeeding, or able to become pregnant, to protect the health of unborn babies and infants, but this means there is little reliable information about how medicines and treatments affect these women and their babies. The authors recommend changing guidelines to allow women to make informed decisions about birth control when joining clinical trials, treating pregnancy and breastfeeding as separate situations, and including women’s perspectives in planning research.

Media release

From: The Lancet

The Lancet: Experts call for more pregnant and breastfeeding women to be included in medical research

Many clinical trials exclude women who are pregnant, breastfeeding, or able to become pregnant. This is often done to protect the health of unborn babies and infants, but it means there is little reliable information about how medicines and treatments affect these women and their babies, according to a new Viewpoint published in The Lancet.

Excluding these populations from research can lead to delays in understanding what treatments are safe and effective during pregnancy and breastfeeding. As a result, doctors must make decisions without strong evidence, which can affect the health of mothers and their children.

The authors recommend changes to medical research guidelines, such as allowing women to make their own informed decisions about birth control when joining clinical trials, treating pregnancy and breastfeeding as separate situations, and including women’s perspectives in planning research. They also suggest new rules and incentives to encourage studies that include pregnant and breastfeeding women.

The authors say these changes can help improve the safety and health of women and their babies by ensuring that medical treatments are properly tested for them.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research The Lancet, Web page The URL will go live after the embargo lifts.
Journal/
conference:
The Lancet
Research:Paper
Organisation/s: McMaster University, Canada
Funder: N/A
Media Contact/s
Contact details are only visible to registered journalists.